Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Katsuya, Naruse"'
Autor:
Kenji Baba, Daisuke Takahashi, Seiji Kamei, Hiroki Numanami, Katsuya Naruse, Akihito Kubo, Emiko Takahashi, Etsuro Yamaguchi, Masayuki Haniuda, Eisuke Katsuda, Toyoharu Yokoi
Publikováno v:
Internal medicine (Tokyo, Japan). 54(1)
A 50-year-old man with a history of smoking of 45 pack-years underwent right lower lobectomy after neoadjuvant chemoradiotherapy for locally advanced non-small cell lung cancer diagnosed on a bronchial biopsy and standard imaging examinations, includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d0933300800ee0e476872e3bbc8ab69
https://pubmed.ncbi.nlm.nih.gov/25742895
https://pubmed.ncbi.nlm.nih.gov/25742895
Autor:
Shigeyuki Aoki, Nobuaki Honda, Hideto Iwafuchi, Katsuya Naruse, Yoshiaki Yamada, Tomohiro Taki
Publikováno v:
International Journal of Urology. 14:248-250
This report describes a case of primary leiomyoma of the ureter in which only partial ureterectomy was performed based on the diagnosis of benign tumor by rapid diagnosis using a frozen section during the operation. Surgical treatment was opted for u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f85e98b79b84cab2e278a81d94a493cc
https://doi.org/10.1111/j.1442-2042.2006.01647.x
https://doi.org/10.1111/j.1442-2042.2006.01647.x
Autor:
Inbou Kyoku, Remi Katsuda, Hiroshi Noguchi, Nobuaki Honda, Maki Arakawa, Yoshiaki Yamada, Takaaki Hasegawa, Hiroko Saito, Yasusuke Inoue, Kogenta Nakamura, Kouji Hara, Kenji Zennami, Shigeyuki Aoki, Tomohiro Taki, Katsuya Naruse, Noriko Mitsutake, Motoi Tobiume
Publikováno v:
Molecular medicine reports. 1(6)
Cyclooxygenase-2 (COX-2) activity is reported to increase apoptosis, inhibit angiogenesis and reduce metastasis. We analyzed COX-2 expression in patients with invasive bladder cancer to evaluate the feasibility of selective COX-2 inhibitor treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1706bd4eedccd24a1008f19253bfd846
https://pubmed.ncbi.nlm.nih.gov/21479487
https://pubmed.ncbi.nlm.nih.gov/21479487
Autor:
Yoshiaki Yamada, Genya Nishikawa, Tomohiro Taki, Hatsuki Hibi, Remi Katsuda, Shigeyuki Aoki, Masahito Watanabe, Youko Itoh, Nobuaki Honda, Kenji Mitsui, Katsuya Naruse, Kogenta Nakamura, Kenji Zennami
Publikováno v:
Oncology Reports. 23
Expression of HER-2 and COX-2 was determined to assess the potential of molecular-targeted therapy against human epidermal growth factor receptor-2 (HER-2) and cyclooxygenase-2 (COX-2) for the treatment of invasive bladder cancer. The subjects were 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::356e72280bff08642cd1a7aa67bc1ed1
https://doi.org/10.3892/or_00000798
https://doi.org/10.3892/or_00000798
Autor:
Nobuaki Honda, Kenji Zennami, Yoshiaki Yamada, Tomohiro Taki, Kogenta Nakamura, Miho Nishimura, Motoi Tobiume, Youko Itoh, Katsuya Naruse, Hiroshi Nanaura, Genya Nishikawa, Yoshitaka Muramatsu, Kazuko Takii, Adnan Odhafa Kh Adham
Publikováno v:
Experimental and therapeutic medicine. 1(4)
It has not yet been determined whether certain types of prostate cancer with bone metastasis (M1b PC) are associated with a poor outcome. The present study retrospectively assessed the potential significance of various clinical data in predicting the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be8a51932a63d8006770d6aa3d5c1448
https://pubmed.ncbi.nlm.nih.gov/22993586
https://pubmed.ncbi.nlm.nih.gov/22993586
Autor:
Kenji Zennmai, Hiroko Saito, Nobuaki Honda, Remi Katsuda, Kogenta Nakamura, Shigeyuki Aoki, Maki Arakawa, Charles J. Rosser, Motoi Tobiume, Masahito Watanabe, Yoshiaki Yamada, Tomohiro Taki, Katsuya Naruse, Takaaki Hasegawa, Yoshiharu Kato
Publikováno v:
Oncology letters. 1(1)
Zoledronic acid (ZOL) is a new generation bisphosphonate with improved efficacy benefits over pamidronate in preclinical testing. In addition, ZOL is superior to pamidronate in the treatment of hypercalcemia of malignancy. ZOL is also the first bisph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22e799124bf7ed2f73ab2f9c1546b255
https://pubmed.ncbi.nlm.nih.gov/22966248
https://pubmed.ncbi.nlm.nih.gov/22966248
Autor:
Tomohiro Taki, Mariko Nakahira, Akiko Kitamura, Yoshiharu Kato, Kogenta Nakamura, Masaki Sawada, Kenji Zennami, Sayaka Ukai, Motoi Tobiume, Yoshiaki Yamada, Genya Nishikawa, Nobuaki Honda, Katsuya Naruse, Remi Katsuda, Youko Itoh, Masahito Watanabe, Shigeyuki Aoki, Miwako Minami
Publikováno v:
Cancer chemotherapy and pharmacology. 64(6)
We evaluated the efficacy and safety of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced metastatic transitional cell carcinoma of the urothelium.The subjects were 12 patients diagnosed with advanced metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3124886ad132f47fecc89e337a01b953
https://pubmed.ncbi.nlm.nih.gov/19277660
https://pubmed.ncbi.nlm.nih.gov/19277660
Autor:
Nobuaki Honda, Katsuya Naruse, Kenji Zennami, Yoshiaki Yamada, Hiroyuki Matsubara, Tomohiro Taki, Motoi Tobiume, Shigeyuki Aoki, Kogenta Nakamura, Remi Katsuda
Publikováno v:
Oncology Reports.
Analysis of HER-2/neu expression in invasive bladder carcinoma was performed in order to evaluate the potential for molecular targeted therapy targeting HER-2. The subjects were 40 patients who were pathologically diagnosed with invasive transitional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::095ba207c84380f33e3741d1b609fec8
https://doi.org/10.3892/or.19.1.57
https://doi.org/10.3892/or.19.1.57
Autor:
Keiko Hayashida, Remi Katsuda, Nobuaki Honda, Kogenta Nakamura, Shigeyuki Aoki, Kenji Zennami, Miki Hirano, Yoshiaki Yamada, Motoi Tobiume, Emi Mizumukai, Tomohiro Taki, Katsuya Naruse, Hiroshi Nanaura
Publikováno v:
Oncology reports. 18(5)
Analysis of HER-2/neu gene amplification by fluorescence in situ hybridization was performed in 40 patients with invasive bladder cancer in order to evaluate the potential for molecular targeted therapy of HER-2 as a tailor-made treatment for patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e03608f0d337a248596cc49a3c0ab365
https://pubmed.ncbi.nlm.nih.gov/17914570
https://pubmed.ncbi.nlm.nih.gov/17914570
Autor:
Katsuya, Naruse, Yoshiaki, Yamada, Shigeyuki, Aoki, Tomohiro, Taki, Kogenta, Nakamura, Motoi, Tobiume, Kenji, Zennami, Remi, Katsuda, Shotoku, Sai, Yoshitaka, Nishio, Yasusuke, Inoue, Hiroshi, Noguchi, Nobuaki, Hondai
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 53(5)
We analyzed clinical data to identify prognostic indicators in prostate cancer patients with bone metastasis. The subjects were 60 patients with bone metastasis out of 165 patients diagnosed with prostate cancer at our clinic over 6 years from Januar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff3de53574ccc42a888924d5132abfc3
https://pubmed.ncbi.nlm.nih.gov/17561711
https://pubmed.ncbi.nlm.nih.gov/17561711